IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

DC Funds, LP

Q2 2026 Holdings

Filed 2026-08-14 | 3 holdings | $1.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Tscan Therapeutics Inc(TCRX)COM89854M101$617.5K630,00049.3%
Barinthus Biotherapeutics PL(BRNS)ADS91864C107$423.9K642,20433.8%
Werewolf Therapeutics Inc(HOWL)COM95075A107$212.0K589,10216.9%